Skip to content
Open access

Prognostic value of epicardial and pericardial adipose tissue in patients with chronic heart failure

Sep 2026 · Netherlands Heart Journal · Vol 34, pp. 369 - 379 · 0 citations · 31 references
Medicine

TL;DR

It is hypothesized that epicardial and pericardial adipose tissue (EAT and PAT) are easily obtainable on standard echocardiography and provide prognostic value in patients with HF and may serve as a valuable prognostic marker in chronic HF.

Abstract

Central obesity, rather than overall obesity, may influence heart failure (HF) outcomes. Alternative anthropometric measures remain limited in assessing the actual amount and distribution of visceral adiposity. We hypothesize that epicardial and pericardial adipose tissue (EAT and PAT) are easily obtainable on standard echocardiography and provide prognostic value in patients with HF. In total, 572 patients with HF with reduced, mildly reduced and preserved ejection fraction (HFrEF, HFmrEF, and HFpEF, respectively) were included. EAT (the adipose tissue between the myocardium and the visceral layer of the pericardium) and PAT (the adipose tissue outside the parietal layer of the pericardium) thickness were measured on echocardiography and expressed in mm. Patients were followed for the combined outcome of all-cause mortality and HF hospitalization. Mean age was 67 ± 14 years, 38% were women, 346 had HFrEF, 100 had HFmrEF and 126 had HFpEF. Mean body mass index (BMI) was 27 ± 6 kg/m2, mean EAT thickness 4.8 ± 2.1 mm, and mean PAT thickness 5.7 ± 2.8 mm. During a median follow-up of 3.2 ± 1.9 years, both EAT and PAT thickness were associated with an increased risk for the combined outcome [HR 1.15 (95% CI 1.03–1.30), p = 0.006 and HR 1.25 (95% CI 1.10–1.41), p < 0.001, respectively], whereas BMI was not. In a multivariable model, only PAT thickness remained associated with poor outcome [HR 1.49 per SD (95% CI 1.10–2.03), p = 0.011]. Increased PAT thickness, more than EAT, assessed on routine echocardiography, may serve as a valuable prognostic marker in chronic HF.

Read PDF

Similar papers

Open access Oct 2026

The association between heart rate variability, epicardial adipose tissue, and clinical outcomes in heart failure patients

Lower 24-hour HRV (SDNN/SDANN) is associated with adverse epicardial fat remodeling (higher density and larger volume) and independently predicts HF rehospitalization or death and this association is particularly strong in HFrEF, suggesting a phenotype-specific neuro-adipose axis.

Y. Yu, W. Lin, L. Shen et al. · 0 citations
Sep 2026

Epicardial adipose tissue attenuation as an independent marker of cardiovascular outcomes in de novo heart failure (RECOVER-EAT).

BACKGROUND Epicardial adipose tissue (EAT) is a visceral fat depot implicated in cardiovascular disease. While EAT volume has been associated with risk, it provides limited information regarding adipose tissue composition. Computed tomography (CT)-derived EAT attenuation is a marker of adipose tissue composition, but i...

S. Khanna, N. McLellan, S. Vasanthakumar et al. · 1 citation
Open access Oct 2026

Thickness of epicardial adipose tissue reflects the metabolic and cardiovascular status of patients in T1DM population

Epicardial adipose tissue (EAT) is defined as the fatty layer located between the visceral pericardium (epicardium) and the myocardial surface. EAT is not simply a passive fat depot but an active endocrine organ linking metabolic disturbances to cardiovascular complications. According to the literature, its thick...

K. Garmpis, M. Hajdu, N. Varga et al. · 0 citations
Review Open access Oct 2026

Epicardial adipose tissue thickness measured by echocardiography is associated with metabolic syndrome in a surgical cohort of patients with coronary artery disease and valvular heart disease

Epicardial adipose tissue (EAT) is a visceral fat depot that can be assessed by routine echocardiography and may reflect cardiometabolic risk beyond visceral adiposity. Metabolic syndrome (MetS) is associated with an increased risk of type 2 diabetes, cardiovascular disease and all-cause mortality. If EAT is asso...

F. Opdahl, T. Toennessen, S. Solheim et al. · 0 citations
Nov 2026

Abstract 8830: Prognostic Value of Epicardial Adipose Tissue Volume-to-Density Ratio in Heart Failure with Pulmonary Hypertension: The Modulatory Role of Systemic Inflammation

Background: Epicardial adipose tissue (EAT) volume (EATV) and density (EATD) are emerging imaging biomarkers for cardiovascular risk, yet their combined prognostic value in heart failure (HF) complicated by pulmonary hypertension (PH) remains unclear. PH due to left heart disease (WHO Group 2 PH) affects up to 60-80...

Meng-Xuan Wang, Shuang Yin, Jing Zeng et al. · 0 citations
Open access Oct 2026

Association of Cardiac MRI-Derived Epicardial Adipose Tissue Index With Adverse Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.

BACKGROUND The clinical relevance of the epicardial adipose tissue index (EATI) is increasingly recognized, but its association with clinical outcomes in patients with heart failure with preserved ejection fraction (HFpEF) remains inadequately investigated. PURPOSE To evaluate the association between cardiac MRI-deri...

Si-Ying Ma, Lu-Jie Qian, Kaihua Lou et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.